Loading...
Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men
Non-alcoholic steatohepatitis (NASH) is the most rapidly growing liver disease that is nevertheless without approved pharmacological treatment. Despite great effort in developing novel NASH therapeutics, many have failed in clinical trials. This has raised questions on the adequacy of preclinical mo...
Saved in:
| Published in: | Sci Rep |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group UK
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7930243/ https://ncbi.nlm.nih.gov/pubmed/33658534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-83974-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|